Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is active and no longer recruiting. It studies Hiv, NAFLD and 1 more condition. The registry lists an enrollment of 1,250 participants at 8 sites in 1 country. The registry lists a start date of 19 Jul 2021 and a primary completion date of 1 Sept 2031. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04795219 |
| Status | Active not recruiting |
| Study type | Observational study |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 1,250 |
| Registered sites | 8 |
| Countries | 1 |
| Conditions | Hiv, NAFLD and NAFLD-HIV |
| Start | 19 Jul 2021 |
| Primary completion | 1 Sept 2031 |
| Study completion | 30 Sept 2031 |
| Last update posted | 23 Jan 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jennifer Price, MD, PhD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Tuscaloosa
- University of California, San Diego
La Jolla
- University of California, San Francisco
San Francisco
- Indiana University School of Medicine
Indianapolis
- John Hopkins University
Baltimore
- Duke University
Durham
- University of Texas
Houston
- Virginia Commonwealth University
Richmond
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04795219
Each answer restates registry values shown on this page.
What is NCT04795219?
NCT04795219 is an observational study sponsored by University of California, San Francisco. It studies Hiv, NAFLD and 1 more condition.
Is NCT04795219 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT04795219?
The registry names Jennifer Price, MD, PhD (principal investigator, University of California, San Francisco) and Jordan Lake, MD, MSc (principal investigator, University of Texas) as overall officials.
Where does NCT04795219 run?
The registry lists 8 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT04795219 expected to complete?
The registry lists a primary completion date of 1 Sept 2031 and a study completion date of 30 Sept 2031. The sponsor last updated the record on 23 Jan 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.